Artificial Kidney Prototype: UCSF Kidney Project's KidneyX Prize

Facebook ↗WhatsApp ↗

Originally published 2021-10-06.

The Kidney Project's Implantable-Device Research in 2021

Prototype implantable artificial kidney. Photo: The Kidney Project, UCSF

In September 2021, a research team called The Kidney Project won a $650,000 KidneyX Artificial Kidney Prize for showing that its implantable artificial kidney could work as a single device. The prototype, about the size of a smartphone, ran inside an animal on blood pressure alone, without blood thinners or anti-rejection drugs. It is a real milestone, but it is a preclinical one: the device had not been tested in people, and it is not yet an option for anyone on dialysis or a transplant list.

Here is what the team actually built, what the prize recognised, why the idea matters so much to people with kidney failure, and what still has to happen before it could reach a patient.

What the KidneyX prize recognised

KidneyX is a public-private partnership between the US Department of Health and Human Services and the American Society of Nephrology. It runs prize competitions meant to speed up new treatments for kidney disease, a field where care has changed surprisingly little in decades.

The award The Kidney Project received was a Phase 1 Artificial Kidney Prize. According to the University of California, the team was one of six winners chosen from an international field, and it was honoured specifically for the first demonstration of a working prototype of an implantable bioartificial kidney.

The project is led by bioengineer Shuvo Roy of UC San Francisco and co-led by nephrologist William Fissell of Vanderbilt University Medical Center, with collaborators at several institutions across the United States.

How the device is meant to work

A healthy kidney does two broad jobs. It filters waste and excess water out of the blood, and it fine-tunes the body's chemistry: salt and potassium levels, acid balance, blood pressure signals and more. The Kidney Project splits those jobs between two parts.

The hemofilter

The first part is a filter built from silicon membranes with extremely small, precisely made pores. Blood flows past it and waste products and toxins pass through, much as they would through the filtering units of a natural kidney. Because the pores are so uniform, the filter can work with the pressure of the patient's own circulation rather than an external pump.

The bioreactor

The second part houses living human kidney cells. These cells are there to take over the finer metabolic work a plastic membrane cannot do, such as balancing electrolytes. The difficult trick is keeping them alive and protected: the membranes are designed to let nutrients and signals reach the cells while keeping the patient's immune system out, so that no anti-rejection medication is needed.

The two parts had been tested separately before. What the 2021 experiment showed was that they could be combined in one small housing, implanted in a preclinical model and run together. UCSF did not name the animal or the length of that test in its announcement. In earlier published work, the team reported a seven-day test of its bioreactor in young pigs, in which the human cells stayed healthy and the device stayed free of clots and rejection.

Why an implantable kidney would matter

Kidney failure is far more common than many people realise. Wikipedia's summary of US data puts the number of American adults with chronic kidney disease at over 35 million, most of whom do not know it, and around 557,000 people on dialysis.

Dialysis keeps people alive, but at a cost. Most patients on in-centre haemodialysis spend several hours, three times a week, connected to a machine. Many feel drained afterwards, diets and fluid intake are strictly limited, and travel becomes complicated. Mortality on dialysis remains high.

A transplant is usually the better option, but there are not enough organs. The US government's organ donation site lists nearly 110,000 people on the national transplant waiting list, most of them needing a kidney, and reports that 12 people die each day waiting for an organ. Even a successful transplant comes with a lifelong commitment to immunosuppressant drugs, which raise the risk of infections and some cancers.

That is the gap The Kidney Project is aiming at. Roy has said the vision is to offer patients "complete mobility and better physiological outcomes than dialysis." An implant that ran on the body's own blood pressure, needed no external machine and required no anti-rejection drugs would change daily life for hundreds of thousands of people.

What has to happen before human trials

The honest answer is: a lot. The 2021 result was a proof that the concept can work in a scaled-down form. The team's own next steps, as described by UCSF, were to scale the technology up for more rigorous preclinical testing and only then move towards clinical trials.

Some of the open questions are practical:

  • Size and capacity. The tested device was a smaller version. A full-sized model has to clean enough blood to replace kidney function in an adult.
  • Durability. An implant has to work for years without clogging, scarring over or losing its living cells.
  • Getting rid of urine. The filtered fluid has to be routed safely to the bladder.
  • Safety without blood thinners. Blood clots are a constant risk whenever blood flows over artificial surfaces.
  • Regulatory approval. Any device must pass staged human trials and review by the US Food and Drug Administration.

Researchers involved have spoken of hoping to complete FDA trials around 2030, but timelines for first-of-their-kind implants often slip, so it is wise to treat any date as a goal rather than a promise.

Common misunderstandings about artificial kidneys

"Scientists have invented a working artificial kidney." Not for humans yet. The 2021 milestone was in animals, and a scaled-down version at that.

"It will replace transplants soon." Even in the best case, an implantable kidney would first be tested in small numbers of patients. Transplants and dialysis will remain the standard treatments for years.

"Artificial kidneys are a new idea." The first working dialysis machine was built by Willem Kolff in the Netherlands in 1943, and a dialyser is itself a kind of artificial kidney. What is new is the attempt to make one small enough to implant and smart enough to include living cells. Other groups are working on wearable dialysis devices that a patient could carry rather than implant.

"Kidney disease only affects older people." Age is a risk factor, but diabetes and high blood pressure are the leading causes, and both are common across age groups.

What this means if you or someone you love has kidney disease

An implantable kidney is not something patients can sign up for today, and it is best to be wary of any clinic or website that claims otherwise. The most useful steps remain the familiar ones: keep blood pressure and blood sugar under control, ask about kidney function tests if you have diabetes, high blood pressure or a family history, and talk to a doctor about the options that exist now, including home dialysis and getting evaluated for a transplant early. Registering as an organ donor also directly shortens the waiting list.

The KidneyX prize mattered because it put money and attention behind a field that badly needs both. The prototype that won it is a sign of real progress, and a reminder of how much careful work separates an animal test from a treatment.

Sources: University of California / UCSF: Kidney Project successfully tests prototype bioartificial kidney (16 September 2021); Wikipedia: Artificial kidney; HRSA, organdonor.gov: Organ donation statistics. Photo: The Kidney Project, UCSF. First brought to our attention by Good News Network.

COMMENTS